Add-Aspirin

A phase III, double blind, Placebo controlled, randomized trial assessing the effect of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumor. (Add Aspirin Study).

Study design / Type : A phase III, double blind, Placebo controlled, randomized trial